期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
变应性鼻炎大鼠鼻黏膜纤毛超微结构和鼻症状变化的研究 被引量:12
1
作者 刘建国 刘月辉 《临床耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2010年第8期365-368,共4页
目的:通过变应原诱发大鼠变应性鼻炎(AR),观察鼻黏膜纤毛超微结构和鼻腔症状变化的特点。方法:采用卵清蛋白(OVA)为变应原激发大鼠鼻黏膜建立AR大鼠模型,建模成功后,每周2次鼻腔激发,分别至16 d、42 d、56 d、112 d、140 d。正常对照组... 目的:通过变应原诱发大鼠变应性鼻炎(AR),观察鼻黏膜纤毛超微结构和鼻腔症状变化的特点。方法:采用卵清蛋白(OVA)为变应原激发大鼠鼻黏膜建立AR大鼠模型,建模成功后,每周2次鼻腔激发,分别至16 d、42 d、56 d、112 d、140 d。正常对照组在整个试验过程中以生理盐水代替OVA。观察变应原激发后的鼻黏膜纤毛超微结构改变以及检测鼻黏膜中浸润的嗜酸粒细胞(EOS)情况,同时观察变应原诱导的大鼠鼻腔流涕症状。结果:暴露变应原会引起大鼠鼻黏膜细胞纤毛排列紊乱,有的纤毛粘集成团向不同方向倾倒,上皮纤毛和绒毛多数脱落等超微结构进行性损害改变,EOS浸润先增多后降低;抓鼻次数变化无统计学意义,而鼻腔流涕症状起初一直加重,随着暴露变应原时间的延长出现鼻涕排除障碍。结论:AR大鼠模型在延长变应原诱导下鼻黏膜纤毛呈进行性损害;此外,长期变应原攻击下鼻腔症状变化可能与鼻黏膜纤毛结构进行性损害有关。 展开更多
关键词 纤毛 鼻变应原 应性 腔症状 超微结构
原文传递
氯雷他定联合鼻阻隔剂治疗变应性鼻炎的临床观察
2
作者 马梽轩 孙海波 任晓楠 《中国医学文摘(耳鼻咽喉科学)》 2017年第5期254-255,239,共3页
目的观察氯雷他定联合鼻用变应原阻隔软膏治疗变应性鼻炎的临床疗效。方法随机将经我院门诊确诊的60例患者分为观察组和对照组2组。对照组单独使用氯雷他定10 mg睡前口服,连续口服治疗2周。观察组使用氯雷他定10 mg睡前口服。同时应用... 目的观察氯雷他定联合鼻用变应原阻隔软膏治疗变应性鼻炎的临床疗效。方法随机将经我院门诊确诊的60例患者分为观察组和对照组2组。对照组单独使用氯雷他定10 mg睡前口服,连续口服治疗2周。观察组使用氯雷他定10 mg睡前口服。同时应用鼻用变应原阻隔软膏治疗,疗程2周,分别于治疗前、治疗1周、治疗结束后进行鼻腔症状评分。比较治疗效果。结果治疗第1周2组患者症状评分均优于治疗前(P<0.05),2组间疗效比较,观察组略好于对照组,但无明显差异(P>0.05);治疗第2周观察组症状评分优于对照组(P<0.05)。结论氯雷他定联合鼻用变应原阻隔软膏治疗变态反应性鼻炎效果优于单纯应用氯雷他定,但鼻用变应原阻隔软膏起效时间较长(约1周),临床使用时可考虑预防性用药。 展开更多
关键词 应性 季节性 应原阻隔软膏
原文传递
局部变应性鼻炎概述 被引量:8
3
作者 胡秋蓉 李靖 《临床耳鼻咽喉头颈外科杂志》 CAS 北大核心 2018年第17期1363-1366,共4页
变应性鼻炎(allergic rhinitis,AR)是机体暴露于变应原后主要由IgE介导的鼻黏膜非感染性慢性炎性疾病,其诊断包括典型症状如阵发性喷嚏、清水样涕、鼻痒、鼻塞和至少1种变应原检测试验如变应原皮肤点刺试验(skin prick test,SPT)和... 变应性鼻炎(allergic rhinitis,AR)是机体暴露于变应原后主要由IgE介导的鼻黏膜非感染性慢性炎性疾病,其诊断包括典型症状如阵发性喷嚏、清水样涕、鼻痒、鼻塞和至少1种变应原检测试验如变应原皮肤点刺试验(skin prick test,SPT)和(或)血清特异性IgE阳性。若患者症状和AR症状相似,但变应原检测试验均阴性,则诊断为非变应性鼻炎(non-allergic rhinitis,NAR)。 展开更多
关键词 局部应性 免疫球蛋白E 应原激发试验 发病机制 免疫治疗
原文传递
Science Letters:A synthetic Toll-like receptor 2 ligand decreases allergic immune responses in a mouse rhinitis model sensitized to mite allergen 被引量:6
4
作者 Cheng ZHOU Xiao-dong KANG Zhi CHEN 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2008年第4期279-285,共7页
It has been proposed that activation of Toll-like receptors (TLRs) plays crucial roles in the polarization of adaptive immune responses. A synthetic Toll-like receptor 2 (TLR2) ligand, Pam3CSK4, has been reported ... It has been proposed that activation of Toll-like receptors (TLRs) plays crucial roles in the polarization of adaptive immune responses. A synthetic Toll-like receptor 2 (TLR2) ligand, Pam3CSK4, has been reported to modulate the balance of Th1/Th2 responses. We evaluated the modulation effect of Pam3CSK4 on allergic immune response in a mouse rhinitis model sensitized to house dust mite allergen (HDM). Mice were sensitized and challenged with Dermatophagoidesfarinae allergen (Der f), and then the allergic mice were treated by Pam3CSK4. Nasal allergic symptoms and eosinophils were scored. Der f-specific cytokine responses were examined in the splenocytes and bronchoalveolar lavage fluid (BALF). Serum level of total IgE was also detected. After establishing a mouse allergic rhinitis model with HDM, we have showed that Pam3CSK4 treatment not only ameliorated the nasal allergic symptoms remarkably but also decreased the eosinophils and total inflammation cells in BALF significantly. Analysis of cytokine profile found that IFN-7 released from either BALF or stimulated splenocytes increased markedly in Pam3CSK4-treated mice, while IL-13 decreased significantly. Moreover, serum level of total IgE was significantly lower in Pam3CSK4-treated mice than in the untreated. Thus, in an allergic rhinitis mouse model developed with HDM, Pam3CSK4 was shown to exhibit an antiallergic effect, indicating its potential application in allergic diseases. 展开更多
关键词 Toll-like receptor 2 (TLR2) LIGAND Allergic immune response Mite allergen
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部